Stay updated on PD-1 Inhibitor Combo with Gem/Cispl Clinical Trial
Sign up to get notified when there's something new on the PD-1 Inhibitor Combo with Gem/Cispl Clinical Trial page.
Latest updates to the PD-1 Inhibitor Combo with Gem/Cispl Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this appears to be a minor backend/version change with no visible impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 is shown on the page. The update does not alter study details, eligibility criteria, outcomes, or other core content.SummaryDifference0.1%
- Check49 days agoChange DetectedFooter revision updated to v3.3.3; the previous revision and the HHS Vulnerability Disclosure entry were removed.SummaryDifference0.1%
- Check78 days agoChange DetectedAdded an explanatory note that publications are auto-filled from PubMed, and a new Revision: v3.3.2 appeared on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check86 days agoChange DetectedThe government funding lapse notice about site status and update sources was removed from the page.SummaryDifference0.4%
- Check100 days agoChange DetectedThe page layout and styling have been updated, with sections reorganized. Core study details, including title, interventions, outcomes, eligibility criteria, and contact information, appear unchanged.SummaryDifference0.5%
Stay in the know with updates to PD-1 Inhibitor Combo with Gem/Cispl Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibitor Combo with Gem/Cispl Clinical Trial page.